Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Summary

Lifecore (NASDAQ: LFCR) granted a restricted stock unit award for 5,000 shares as an inducement to a newly hired employee, effective April 20, 2026. The award was approved by the compensation committee under the company’s Equity Inducement Plan and Nasdaq Listing Rule 5635(c)(4).

The RSUs vest and will be settled on the third anniversary of the grant date, subject to continued employment, and are governed by an award agreement and the Inducement Plan.

News Market Reaction – LFCR

-5.93%

1 alert

-5.93% Session close to close

$205.94M Market Cap

0.0x Rel. Volume

In the Apr 23 session, LFCR declined 5.93%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -5.9% in the session following this news. A negative reaction despite this routine i...

Analysis

The stock moved -5.9% in the session following this news. A negative reaction despite this routine inducement RSU grant of 5,000 shares would fit a pattern where LFCR has previously declined after generally positive or neutral announcements, including the Mar 16, 2026 earnings update. Investors have also contended with overhang from registered resale capacity under the Form S-3 and the capital structure complexity noted in recent filings, which may weigh on sentiment around even small equity awards.

Key Figures

Inducement RSU size: 5,000 shares

1 metrics

Inducement RSU size 5,000 shares Restricted stock unit grant under Equity Inducement Plan effective April 20, 2026

Historical Context

5 past events · Latest: Apr 08 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 08	Conference participation	Neutral	+3.2%	Participation at American Biomanufacturing Summit and investor outreach plans.
Mar 26	Inducement RSU grant	Neutral	-5.4%	Inducement RSU award of 18,500 shares to a new employee.
Mar 26	CDMO agreements	Positive	-7.6%	Two new CDMO manufacturing agreements expected to add to late-stage pipeline.
Mar 23	Site transfer deal	Positive	+0.8%	Commercial site transfer agreement for an aesthetic sterile product with revenue potential.
Mar 16	Earnings and update	Positive	-24.4%	Improved revenue, margins, and EBITDA with 2026 guidance and liquidity update.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent history shows multiple positive corporate updates followed by negative price reactions, suggesting a pattern of selling into good news.

Recent Company History

Over the past months, Lifecore reported improved financials and multiple CDMO agreements. The Mar 16, 2026 earnings update highlighted revenue of $75.5M, better margins, and stronger Adjusted EBITDA, yet the stock fell 24.39%. New CDMO deals in late March and a commercial site transfer agreement tied to future revenue also saw mixed to negative reactions. Today’s inducement RSU grant continues routine governance and compensation activity under the company’s existing equity plans.

Key Terms

restricted stock unit, equity inducement plan, nasdaq listing rule 5635(c)(4), cdmo

4 terms

restricted stock unit financial

"Lifecore granted a restricted stock unit (“RSU”) award with respect to 5,000 shares"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

equity inducement plan financial

"under Lifecore’s Equity Inducement Plan, as amended (the “Inducement Plan”)"

An equity inducement plan is a program that gives new hires or targeted employees stock, restricted shares, or stock options as a hiring or retention reward, often separate from the company’s regular long-term incentive plans. Think of it as a signing bonus paid in company stock: it helps attract and keep talent but matters to investors because it can dilute existing shares, change executive incentives, and affect future earnings through compensation expense.

nasdaq listing rule 5635(c)(4) regulatory

"as inducement equity award in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

cdmo technical

"a fully integrated injectables contract development and manufacturing organization (“CDMO”)"

A contract development and manufacturing organization (CDMO) is a company that provides specialized services to help develop and produce pharmaceutical products for other businesses. Think of it as a contract factory that takes a company's recipe and makes the product on their behalf. For investors, CDMOs are important because they support the growth of pharmaceutical companies and can be key partners in bringing new medicines to market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CHASKA, Minn., April 22, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that effective on April 20, 2026, Lifecore granted a restricted stock unit (“RSU”) award with respect to 5,000 shares of its common stock under Lifecore’s Equity Inducement Plan, as amended (the “Inducement Plan”) to a newly hired employee of Lifecore. The RSU award was granted pursuant to the offer letter between Lifecore and the employee, and as a material inducement to the employee joining Lifecore.

The RSU award was approved by Lifecore’s compensation committee and was granted as inducement equity award in accordance with Nasdaq Listing Rule 5635(c)(4) under the Inducement Plan.

The RSUs will vest and be settled on the third anniversary of the grant date, subject to continued employment. The RSU award is governed by an award agreement and the Inducement Plan.

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

Lifecore Biomedical, Inc. Contact Information:

Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com

Jennifer Arcure (Media)
917-603-0681
jarcure@vidasp.com

Lifecore Biomedical
Ryan D. Lake (CFO)
952-368-6244
ryan.lake@lifecore.com

FAQ

What did Lifecore (LFCR) announce about the 5,000-share RSU award on April 22, 2026?

Lifecore granted a restricted stock unit award covering 5,000 shares as an inducement to a newly hired employee. According to Lifecore, the award was effective April 20, 2026 and approved by the compensation committee under the Inducement Plan.

When will the Lifecore (LFCR) RSUs vest and be settled?

The RSUs will vest and be settled on the third anniversary of the grant date, subject to continued employment. According to Lifecore, settlement timing is governed by the award agreement and the Inducement Plan.

Under which Nasdaq rule was Lifecore's (LFCR) inducement RSU award granted?

The award was granted in accordance with Nasdaq Listing Rule 5635(c)(4) as an inducement equity award. According to Lifecore, the compensation committee approved the grant under the company's Equity Inducement Plan.

Why did Lifecore (LFCR) issue the 5,000-share RSU award to the new hire?

The RSU award was issued as a material inducement to recruit a newly hired employee. According to Lifecore, the award was provided pursuant to the offer letter and governed by the Inducement Plan and award agreement.

Does Lifecore (LFCR) say the RSU award affects outstanding shares or dilution?

The announcement does not state any specific impact on outstanding shares or dilution. According to Lifecore, the notice only details the 5,000-share RSU grant, vesting terms, and governance under the Inducement Plan.